Raplixa case study: Enabling an innovative drug presentation through aseptic spray drying.
| Publicado en: | Pharmaceutical Technology Vol. 40; no. 7; p. 26 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Jul2016
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=116756928&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 116756928 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15432521 4FK jtl: Pharmaceutical Technology issn: 15432521 maglogo: N pubinfo: dt: Jul2016 vid: 40 iid: 7 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 116756928 116756928 ppf: 26 ppct: 0 formats: fmt: @attributes: type: P tig: atl: Raplixa case study: Enabling an innovative drug presentation through aseptic spray drying. aug: au: de Costa, Sam affil: stabilization project manager at Nova Laboratories sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|